Literature DB >> 15481451

Successful allogeneic bone marrow transplantation in a patient with acute myelogenous leukemia and cytomegalovirus retinitis.

Hiroshi Matsubara1, Souichi Adachi, Jun Yano, Noriko Kitamura, Maki Miyazaki, Yasuhiro Mizushima, Hidefumi Hiramatsu, Michihiro Kobayashi, Tatsutoshi Nakahata.   

Abstract

A 1-year-old boy with acute myeloid leukemia with cytomegalovirus (CMV) retinitis that was refractory because of severely impaired cellular immunity underwent bone marrow transplantation from an HLA-matched donor after a conditioning regimen of busulfan, cyclophosphamide, and etoposide. Although we continued administration of ganciclovir from preparation therapy, retinitis worsened after engraftment. Thereafter retinitis improved gradually as the number of CD4+ T-lymphocytes increased. The findings in this case suggest that stem cell transplantation for a leukemia patient with CMV disease may be effective.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15481451     DOI: 10.1532/ijh97.04041

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  15 in total

1.  Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease.

Authors:  S Chou; G Marousek; S Guentzel; S E Follansbee; M E Poscher; J P Lalezari; R C Miner; W L Drew
Journal:  J Infect Dis       Date:  1997-09       Impact factor: 5.226

2.  Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease.

Authors:  H Krause; H Hebart; G Jahn; C A Müller; H Einsele
Journal:  Bone Marrow Transplant       Date:  1997-06       Impact factor: 5.483

3.  Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection.

Authors:  J W Gratama; J W van Esser; C H Lamers; C Tournay; B Löwenberg; R L Bolhuis; J J Cornelissen
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

4.  Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.

Authors:  D A Jabs; C Enger; M Forman; J P Dunn
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

5.  Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

Authors:  A P Limaye; L Corey; D M Koelle; C L Davis; M Boeckh
Journal:  Lancet       Date:  2000-08-19       Impact factor: 79.321

6.  Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals.

Authors:  Barbara Savoldo; Michael L Cubbage; April G Durett; John Goss; M Helen Huls; Zhensheng Liu; Lopez Teresita; Adrian P Gee; Paul D Ling; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

7.  Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis.

Authors:  A Erice; N Borrell; W Li; W J Miller; H H Balfour
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

8.  Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan.

Authors:  Akira Tomonari; Tohru Iseki; Jun Ooi; Satoshi Takahashi; Motohiro Shindo; Koji Ishii; Fumitaka Nagamura; Kaoru Uchimaru; Kenzaburo Tani; Arinobu Tojo; Shigetaka Asano
Journal:  Br J Haematol       Date:  2003-04       Impact factor: 6.998

9.  Successful unrelated cord blood transplantation in an infant with Wiskott-Aldrich syndrome following recurrent cytomegalovirus disease.

Authors:  Michiya Kaneko; Tsutomu Watanabe; Hiroyoshi Watanabe; Masahiro Kimura; Hiroko Suzuya; Yasuhiro Okamoto; Ryuji Nakagawa; Yasuhiro Kuroda
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

10.  Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis.

Authors:  C R Li; P D Greenberg; M J Gilbert; J M Goodrich; S R Riddell
Journal:  Blood       Date:  1994-04-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.